2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

TA McDonagh, M Metra, M Adamo… - European heart …, 2021 - academic.oup.com
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

ST-segment elevation myocardial infarction

B Vogel, BE Claessen, SV Arnold, D Chan… - Nature reviews Disease …, 2019 - nature.com
ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of
coronary artery disease and is associated with great morbidity and mortality. A complete …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

[PDF][PDF] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

P Ponikowski, AA Voors, SD Anker… - Kardiologia Polska …, 2016 - journals.viamedica.pl
5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

[HTML][HTML] Atrial and brain natriuretic peptides: Hormones secreted from the heart

Y Nakagawa, T Nishikimi, K Kuwahara - Peptides, 2019 - Elsevier
The natriuretic peptide family consists of three biologically active peptides: atrial natriuretic
peptide (ANP), brain (or B-type) natriuretic peptide (BNP), and C-type natriuretic peptide …

The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications

K Kuwahara - Pharmacology & therapeutics, 2021 - Elsevier
Natriuretic peptides, which are activated in heart failure, play an important cardioprotective
role. The most notable of the cardioprotective natriuretic peptides are atrial natriuretic …

Signaling in muscle contraction

IY Kuo, BE Ehrlich - Cold Spring Harbor perspectives in …, 2015 - cshperspectives.cshlp.org
Signaling pathways regulate contraction of striated (skeletal and cardiac) and smooth
muscle. Although these are similar, there are striking differences in the pathways that can be …

[PDF][PDF] Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

A Ponikowski, AA Voors, SD Anker, H Bueno… - Revista espanola de …, 2016 - orbi.uliege.be
Se recomienda a los profesionales de la salud que tengan en consideración la presente
guía de la ESC en la toma de decisiones clínicas en su ejercicio diario, así como en la …

Late‐life rapamycin treatment reverses age‐related heart dysfunction

JM Flynn, MN O'Leary, CA Zambataro… - Aging cell, 2013 - Wiley Online Library
Rapamycin has been shown to extend lifespan in numerous model organisms including
mice, with the most dramatic longevity effects reported in females. However, little is known …

Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure

S Fu, P Ping, F Wang, L Luo - Journal of biological engineering, 2018 - Springer
As a family of hormones with pleiotropic effects, natriuretic peptide (NP) system includes
atrial NP (ANP), B-type NP (BNP), C-type NP (CNP), dendroaspis NP and urodilatin, with NP …